首页 > 最新文献

Anesthesia and pain medicine最新文献

英文 中文
C-reactive protein-to-albumin ratio is a predictor of 1-year mortality following liver transplantation. c反应蛋白与白蛋白比率是肝移植术后1年死亡率的预测指标。
Pub Date : 2022-10-01 Epub Date: 2022-10-24 DOI: 10.17085/apm.22176
Kyoung-Sun Kim, Hye-Mee Kwon, Jae Hwan Kim, Ji-Woong Yang, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang

Background: Considering the importance of the inflammatory status of recipients on outcomes following liver transplantation (LT), we investigated the association between C-reactive protein-to-albumin ratio (CAR) and one-year mortality following LT and compared it with other parameters reflecting patients' underlying inflammatory status.

Methods: A total of 3,614 consecutive adult LT recipients were retrospectively evaluated. Prognostic parameters were analyzed using area under the receiver operating characteristic curve (AUROC) analysis, and subsequent cutoffs were derived. For survival analysis, Cox proportional hazards and Kaplan-Meier analyses were performed.

Results: The AUROC for CAR to predict one-year mortality after LT was 0.68 (0.65-0.72), which was the highest compared with other inflammatory parameters, with the best cutoff of 0.34. A CAR ≥ 0.34 was associated with a significantly higher one-year mortality rate (13.3% vs. 5.8 %, log-rank P < 0.001) and overall mortality rate (24.5% vs. 12.9%, log-rank P = 0.039). A CAR ≥ 0.34 was an independent predictor of one-year mortality (hazard ratio, 1.40 [1.03-1.90], P = 0.031) and overall mortality (hazard ratio 1.39 [1.13-1.71], P = 0.002) after multivariable adjustment.

Conclusions: Preoperative CAR (≥ 0.34) was independently associated with a higher risk of one-year and overall mortality after LT. This may suggest that CAR, a simple and readily available biomarker, maybe a practical index that may assist in the risk stratification of liver transplantation outcomes.

背景:考虑到受者炎症状态对肝移植(LT)后预后的重要性,我们研究了c反应蛋白与白蛋白比率(CAR)与肝移植后一年死亡率之间的关系,并将其与反映患者潜在炎症状态的其他参数进行了比较。方法:对3614例连续接受肝移植的成人患者进行回顾性评估。使用受试者工作特征曲线下面积(AUROC)分析预后参数,并推导后续截止点。生存分析采用Cox比例风险分析和Kaplan-Meier分析。结果:CAR预测LT术后1年死亡率的AUROC为0.68(0.65-0.72),与其他炎症参数相比最高,最佳截止值为0.34。CAR≥0.34与一年死亡率(13.3%比5.8%,log-rank P < 0.001)和总死亡率(24.5%比12.9%,log-rank P = 0.039)显著升高相关。多变量调整后,CAR≥0.34是1年死亡率(风险比1.40 [1.03-1.90],P = 0.031)和总死亡率(风险比1.39 [1.13-1.71],P = 0.002)的独立预测因子。结论:术前CAR(≥0.34)与肝移植术后一年死亡率和总死亡率的较高风险独立相关。这可能表明CAR作为一种简单易得的生物标志物,可能是一种实用的指标,可能有助于肝移植结果的风险分层。
{"title":"C-reactive protein-to-albumin ratio is a predictor of 1-year mortality following liver transplantation.","authors":"Kyoung-Sun Kim,&nbsp;Hye-Mee Kwon,&nbsp;Jae Hwan Kim,&nbsp;Ji-Woong Yang,&nbsp;In-Gu Jun,&nbsp;Jun-Gol Song,&nbsp;Gyu-Sam Hwang","doi":"10.17085/apm.22176","DOIUrl":"https://doi.org/10.17085/apm.22176","url":null,"abstract":"<p><strong>Background: </strong>Considering the importance of the inflammatory status of recipients on outcomes following liver transplantation (LT), we investigated the association between C-reactive protein-to-albumin ratio (CAR) and one-year mortality following LT and compared it with other parameters reflecting patients' underlying inflammatory status.</p><p><strong>Methods: </strong>A total of 3,614 consecutive adult LT recipients were retrospectively evaluated. Prognostic parameters were analyzed using area under the receiver operating characteristic curve (AUROC) analysis, and subsequent cutoffs were derived. For survival analysis, Cox proportional hazards and Kaplan-Meier analyses were performed.</p><p><strong>Results: </strong>The AUROC for CAR to predict one-year mortality after LT was 0.68 (0.65-0.72), which was the highest compared with other inflammatory parameters, with the best cutoff of 0.34. A CAR ≥ 0.34 was associated with a significantly higher one-year mortality rate (13.3% vs. 5.8 %, log-rank P < 0.001) and overall mortality rate (24.5% vs. 12.9%, log-rank P = 0.039). A CAR ≥ 0.34 was an independent predictor of one-year mortality (hazard ratio, 1.40 [1.03-1.90], P = 0.031) and overall mortality (hazard ratio 1.39 [1.13-1.71], P = 0.002) after multivariable adjustment.</p><p><strong>Conclusions: </strong>Preoperative CAR (≥ 0.34) was independently associated with a higher risk of one-year and overall mortality after LT. This may suggest that CAR, a simple and readily available biomarker, maybe a practical index that may assist in the risk stratification of liver transplantation outcomes.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"420-428"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/3d/apm-22176.PMC9663950.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical incidents associated with pediatric anesthesia: changes over 6 years at a tertiary children's hospital. 与儿科麻醉相关的危重事件:一家三级儿童医院6年来的变化
Pub Date : 2022-10-01 Epub Date: 2022-09-22 DOI: 10.17085/apm.22164
Sung-Ae Cho, Ji-Hyun Lee, Sang-Hwan Ji, Young-Eun Jang, Eun-Hee Kim, Hee-Soo Kim, Jin-Tae Kim

Background: Sustained interest is needed in the characteristics of critical incidents in pediatric anesthesia and related changes, for determining the causes and degree of potential harm; this will also improve the quality of medical care. This study aimed to analyze the incidence of critical incidents recorded in 2014-2019, and to compare them with those in 2008-2013.

Methods: Critical incidents associated with pediatric anesthesia, including cardiac arrest, recorded in a voluntary departmental reporting system between January 2014 and December 2019 were compared with those reported between January 2008 and August 2013 using chi-square test.

Results: We identified 295 (0.55%) critical incidents from 53,541 cases of pediatric anesthesia (3,471 cardiothoracic surgeries); this is consistent with the previously reported incidence of 0.46%. Among the critical incidents, the incidences of adverse events, sentinel event, near miss case and no-harm events were 93.9%, 1.7%, 0%, and 6.1% in 2014-2019, whereas those were 98.3%, 2.6%, 1.7%, and 0% in 2008-2013 (P = 0.023, 0.686, 0.080, and < 0.001, respectively). Cardiac arrest accounted for 25 (8.5%) cases of the 295 critical events, which significantly lower than that previously reported (18.3%; P = 0.020). Human factor-related events accounted for 61.0% of all critical incidences; this was similar to the previous data (58.5%).

Conclusions: Over six years, there has been no significant difference in the total incidence of critical events. Despite the decrease in the incidence of serious critical events, perioperative care in pediatric anesthesia can be further improved.

背景:为了确定潜在危害的原因和程度,需要持续关注儿科麻醉关键事件的特征和相关变化;这也将提高医疗服务的质量。本研究旨在分析2014-2019年记录的关键事件发生率,并与2008-2013年进行比较。方法:采用卡方检验将2014年1月至2019年12月自愿部门报告系统中记录的与儿科麻醉相关的危重事件(包括心脏骤停)与2008年1月至2013年8月报告的危重事件进行比较。结果:我们从53,541例小儿麻醉(3,471例心胸外科手术)中发现295例(0.55%)危重事件;这与先前报道的0.46%的发病率一致。危重事件中,2014-2019年不良事件、哨点事件、未遂事件和无伤害事件的发生率分别为93.9%、1.7%、0%和6.1%,2008-2013年为98.3%、2.6%、1.7%和0% (P分别为0.023、0.686、0.080和< 0.001)。295例危重事件中,心脏骤停占25例(8.5%),明显低于先前报道的18.3%;P = 0.020)。人为因素相关事件占所有关键事件的61.0%;这与之前的数据(58.5%)相似。结论:6年多来,两组患者危急事件的总发生率无显著差异。尽管严重危重事件的发生率有所下降,但小儿麻醉围手术期护理仍可进一步改善。
{"title":"Critical incidents associated with pediatric anesthesia: changes over 6 years at a tertiary children's hospital.","authors":"Sung-Ae Cho,&nbsp;Ji-Hyun Lee,&nbsp;Sang-Hwan Ji,&nbsp;Young-Eun Jang,&nbsp;Eun-Hee Kim,&nbsp;Hee-Soo Kim,&nbsp;Jin-Tae Kim","doi":"10.17085/apm.22164","DOIUrl":"https://doi.org/10.17085/apm.22164","url":null,"abstract":"<p><strong>Background: </strong>Sustained interest is needed in the characteristics of critical incidents in pediatric anesthesia and related changes, for determining the causes and degree of potential harm; this will also improve the quality of medical care. This study aimed to analyze the incidence of critical incidents recorded in 2014-2019, and to compare them with those in 2008-2013.</p><p><strong>Methods: </strong>Critical incidents associated with pediatric anesthesia, including cardiac arrest, recorded in a voluntary departmental reporting system between January 2014 and December 2019 were compared with those reported between January 2008 and August 2013 using chi-square test.</p><p><strong>Results: </strong>We identified 295 (0.55%) critical incidents from 53,541 cases of pediatric anesthesia (3,471 cardiothoracic surgeries); this is consistent with the previously reported incidence of 0.46%. Among the critical incidents, the incidences of adverse events, sentinel event, near miss case and no-harm events were 93.9%, 1.7%, 0%, and 6.1% in 2014-2019, whereas those were 98.3%, 2.6%, 1.7%, and 0% in 2008-2013 (P = 0.023, 0.686, 0.080, and < 0.001, respectively). Cardiac arrest accounted for 25 (8.5%) cases of the 295 critical events, which significantly lower than that previously reported (18.3%; P = 0.020). Human factor-related events accounted for 61.0% of all critical incidences; this was similar to the previous data (58.5%).</p><p><strong>Conclusions: </strong>Over six years, there has been no significant difference in the total incidence of critical events. Despite the decrease in the incidence of serious critical events, perioperative care in pediatric anesthesia can be further improved.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"386-396"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/e3/apm-22164.PMC9663956.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous epidural balloon neuroplasty: a narrative review of current evidence. 经皮硬膜外球囊神经成形术:现有证据综述。
Pub Date : 2022-10-01 Epub Date: 2022-10-26 DOI: 10.17085/apm.22237
Doo-Hwan Kim, Jin-Woo Shin, Seong-Soo Choi

Percutaneous epidural balloon neuroplasty (PEBN) can be used to perform balloon decompression combined with percutaneous epidural neuroplasty (PEN), leading to significant pain relief and functional improvement in patients with lumbar spinal stenosis. Several studies have demonstrated the effectiveness of PEBN and supported its relatively long-term outcomes (at least 6 months, sustained for up to 12 months). Balloon neuroplasty appears to be superior to conventional PEN. Moreover, it has been shown to be effective in patients unresponsive to conventional PEN or in those with post lumbar surgery syndrome. In addition, balloon neuroplasty achieved successful outcomes regardless of the approach used, such as retrodiscal, transforaminal, contralateral interlaminar, or caudal. Chronic lumbar radicular pain without back pain, neurogenic claudication, and minimal neuropathic component were favorable predictors of successful PEBN from a symptomatic perspective. A short duration of pain after lumbar surgery, lumbar foraminal stenosis caused primarily by degenerative disc, mild foraminal stenosis, and perineural adhesion by degenerative discs were associated with successful outcomes of PEBN from pathological aspects. Ballooning ≥ 50% of the target sites and complete contrast dispersion after ballooning seemed to be crucial for successful outcomes from a technical perspective. In addition, PEBN was effective regardless of the accompanying redundant nerve roots or a mild degree of spondylolisthesis. Studies on balloon neuroplasty have reported occasional minor and self-limiting complications; however, no PEBN-related significant complications have been reported. Given the present evidence, balloon neuroplasty appears to be a safe and effective procedure with minimal complications for the treatment of lumbar spinal stenosis.

经皮硬膜外球囊神经成形术(PEBN)可结合经皮硬膜外神经成形术(PEN)进行球囊减压,从而显著缓解腰椎管狭窄患者的疼痛并改善其功能。多项研究证明了经皮硬膜外神经成形术的有效性,并支持其相对长期的疗效(至少 6 个月,最长可持续 12 个月)。球囊神经成形术似乎优于传统的 PEN。此外,对于对传统 PEN 无反应的患者或患有腰椎手术后综合症的患者,它也被证明是有效的。此外,无论采用后椎间盘、经椎间孔、对侧椎间孔或尾侧等哪种方法,球囊神经成形术都能取得成功。从症状的角度来看,无背痛的慢性腰椎根性疼痛、神经源性跛行和最小的神经病理性成分是预测 PEBN 成功的有利因素。从病理角度看,腰椎手术后疼痛持续时间短、主要由退行性椎间盘引起的腰椎椎间孔狭窄、轻度椎间孔狭窄以及退行性椎间盘引起的神经周围粘连与PEBN的成功预后有关。从技术角度看,球囊扩张≥50%的目标部位和球囊扩张后造影剂完全消散似乎是成功的关键。此外,无论是否伴有多余的神经根或轻度脊柱侧弯,PEBN 都能取得良好效果。有关球囊神经成形术的研究报告称,偶尔会出现一些轻微的、自限性的并发症;但目前还没有与 PEBN 相关的重大并发症报告。鉴于目前的证据,球囊神经成形术似乎是治疗腰椎管狭窄症的一种安全有效且并发症极少的手术。
{"title":"Percutaneous epidural balloon neuroplasty: a narrative review of current evidence.","authors":"Doo-Hwan Kim, Jin-Woo Shin, Seong-Soo Choi","doi":"10.17085/apm.22237","DOIUrl":"10.17085/apm.22237","url":null,"abstract":"<p><p>Percutaneous epidural balloon neuroplasty (PEBN) can be used to perform balloon decompression combined with percutaneous epidural neuroplasty (PEN), leading to significant pain relief and functional improvement in patients with lumbar spinal stenosis. Several studies have demonstrated the effectiveness of PEBN and supported its relatively long-term outcomes (at least 6 months, sustained for up to 12 months). Balloon neuroplasty appears to be superior to conventional PEN. Moreover, it has been shown to be effective in patients unresponsive to conventional PEN or in those with post lumbar surgery syndrome. In addition, balloon neuroplasty achieved successful outcomes regardless of the approach used, such as retrodiscal, transforaminal, contralateral interlaminar, or caudal. Chronic lumbar radicular pain without back pain, neurogenic claudication, and minimal neuropathic component were favorable predictors of successful PEBN from a symptomatic perspective. A short duration of pain after lumbar surgery, lumbar foraminal stenosis caused primarily by degenerative disc, mild foraminal stenosis, and perineural adhesion by degenerative discs were associated with successful outcomes of PEBN from pathological aspects. Ballooning ≥ 50% of the target sites and complete contrast dispersion after ballooning seemed to be crucial for successful outcomes from a technical perspective. In addition, PEBN was effective regardless of the accompanying redundant nerve roots or a mild degree of spondylolisthesis. Studies on balloon neuroplasty have reported occasional minor and self-limiting complications; however, no PEBN-related significant complications have been reported. Given the present evidence, balloon neuroplasty appears to be a safe and effective procedure with minimal complications for the treatment of lumbar spinal stenosis.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"361-370"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/b2/apm-22237.PMC9663944.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporary postoperative myocardial injury and long-term survival in liver transplant patients with coronary artery disease. 冠状动脉疾病肝移植患者术后暂时性心肌损伤与长期生存。
Pub Date : 2022-10-01 Epub Date: 2022-10-26 DOI: 10.17085/apm.22167
Hye-Mee Kwon, Jae Hwan Kim, Ji-Woong Yang, Gyu-Sam Hwang

Background: Coronary artery disease (CAD) is increasing worldwide due to the aging population and cardiometabolic syndrome. However, the extent of postoperative myocardial injury, the most common cause of death during the 30 days after noncardiac surgery, remains unclear with respect to liver transplant (LT) patients with CAD. We examined the link between post-LT high sensitivity cardiac troponin I (hs_cTnI) and long-term survival according to liver disease severity.

Methods: Consecutive patients who underwent LT (n = 3,220) from 2010 to 2020 were evaluated retrospectively. CAD was defined as a history of coronary artery bypass surgery or percutaneous intervention, or previous myocardial infarction. Peak hs_cTnI levels within 30 days post-transplant were compared in patients with and without CAD. The primary endpoint was defined as an all-cause mortality at 12 years following LT. Secondary endpoints include peak hs_cTnI level within post-transplant 30 days and 30-day mortality. Survival analysis was performed using the Kaplan-Meier method.

Results: CAD patients (n = 264, 8.2%) had higher peak hs_cTnI levels within 30 days post-LT than those without CAD (median [interquartile]: 0.068 [0.030-0.154] vs. 0.087 [0.037-0.203] ng/ml, respectively; P = 0.004); however, the mortality rate was comparable (14.7% vs. 14.8%, respectively, P = 0.999), at 12 years, and 1.9% vs. 1.1% (P = 0.522) at 30 days, respectively, at 30 days. Subgroup analysis with stratified liver disease severity identified a similar risk of long-term mortality.

Conclusions: Although the peak hs_cTnI level within 30 days was higher in revascularized or treated CAD patients after LT compared those without CAD, long-term mortality rates at 12 years and 30-day mortality rate were comparable.

背景:由于人口老龄化和心脏代谢综合征,冠状动脉疾病(CAD)在世界范围内呈上升趋势。然而,对于肝移植(LT)冠心病患者,术后心肌损伤(非心脏手术后30天内最常见的死亡原因)的程度仍不清楚。我们根据肝脏疾病的严重程度检查了肝移植后高敏感性心肌肌钙蛋白I (hs_cTnI)与长期生存之间的联系。方法:回顾性分析2010年至2020年连续接受肝移植的患者(n = 3220)。CAD定义为冠状动脉搭桥手术或经皮介入治疗史,或既往心肌梗死史。比较有和无CAD患者移植后30天内hs_cTnI的峰值水平。主要终点定义为移植后12年的全因死亡率。次要终点包括移植后30天内hs_cTnI峰值水平和30天死亡率。采用Kaplan-Meier法进行生存分析。结果:冠心病患者(n = 264, 8.2%)在lt后30天内的hs_cTnI峰值水平高于非冠心病患者(中位数[四分位数间位数]分别为0.068[0.030-0.154]和0.087 [0.037-0.203]ng/ml;P = 0.004);然而,12年时的死亡率是相当的(分别为14.7%对14.8%,P = 0.999), 30天和30天的死亡率分别为1.9%对1.1% (P = 0.522)。分层肝脏疾病严重程度的亚组分析确定了相似的长期死亡率风险。结论:尽管肝移植术后30天内hs_cTnI的峰值高于非冠心病患者,但12年的长期死亡率和30天死亡率是相当的。
{"title":"Temporary postoperative myocardial injury and long-term survival in liver transplant patients with coronary artery disease.","authors":"Hye-Mee Kwon,&nbsp;Jae Hwan Kim,&nbsp;Ji-Woong Yang,&nbsp;Gyu-Sam Hwang","doi":"10.17085/apm.22167","DOIUrl":"https://doi.org/10.17085/apm.22167","url":null,"abstract":"<p><strong>Background: </strong>Coronary artery disease (CAD) is increasing worldwide due to the aging population and cardiometabolic syndrome. However, the extent of postoperative myocardial injury, the most common cause of death during the 30 days after noncardiac surgery, remains unclear with respect to liver transplant (LT) patients with CAD. We examined the link between post-LT high sensitivity cardiac troponin I (hs_cTnI) and long-term survival according to liver disease severity.</p><p><strong>Methods: </strong>Consecutive patients who underwent LT (n = 3,220) from 2010 to 2020 were evaluated retrospectively. CAD was defined as a history of coronary artery bypass surgery or percutaneous intervention, or previous myocardial infarction. Peak hs_cTnI levels within 30 days post-transplant were compared in patients with and without CAD. The primary endpoint was defined as an all-cause mortality at 12 years following LT. Secondary endpoints include peak hs_cTnI level within post-transplant 30 days and 30-day mortality. Survival analysis was performed using the Kaplan-Meier method.</p><p><strong>Results: </strong>CAD patients (n = 264, 8.2%) had higher peak hs_cTnI levels within 30 days post-LT than those without CAD (median [interquartile]: 0.068 [0.030-0.154] vs. 0.087 [0.037-0.203] ng/ml, respectively; P = 0.004); however, the mortality rate was comparable (14.7% vs. 14.8%, respectively, P = 0.999), at 12 years, and 1.9% vs. 1.1% (P = 0.522) at 30 days, respectively, at 30 days. Subgroup analysis with stratified liver disease severity identified a similar risk of long-term mortality.</p><p><strong>Conclusions: </strong>Although the peak hs_cTnI level within 30 days was higher in revascularized or treated CAD patients after LT compared those without CAD, long-term mortality rates at 12 years and 30-day mortality rate were comparable.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"404-411"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/ec/apm-22167.PMC9663948.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized double-blind controlled study comparing erector spinae plane block and thoracic paravertebral block for postoperative analgesia after breast surgery. 一项随机双盲对照研究,比较竖脊肌平面阻滞和胸椎旁阻滞对乳房术后镇痛的影响。
Pub Date : 2022-10-01 Epub Date: 2022-09-20 DOI: 10.17085/apm.22157
Aumjit Wittayapairoj, Nattanan Sinthuchao, Ongart Somintara, Viriya Thincheelong, Wilawan Somdee

Background: Thoracic paravertebral block (PVB) is an effective regional block for pain control after breast surgery. However, accidentally puncturing adjacent vital structures may cause undesirable complications. Erector spinae plane block (ESPB) has been considered a safer proxy of PVB for beginners. This study aimed to evaluate the analgesic effects of ultrasound-guidance PVB and ESPB after breast surgery.

Methods: This randomized control trial was conducted in patients who underwent mastectomy. Forty-four females were randomly allocated into PVB group or ESPB group. All patients received a block with 20 ml of 0.5% levobupivacaine before general anesthesia. The primary outcome was the 24-h postoperative morphine requirements. The other outcomes of interest were postoperative pain scores, time to first analgesic request, dermatome of sensory blockade, block-related complications, and opioid adverse events.

Results: The 24-h morphine requirements were significantly lower in PVB compared to the ESPB group (3.5 ± 3.3 vs. 8.6 ± 3.8 mg, P < 0.001). The overall pain scores were also lower in the PVB group (P < 0.001). Only 14 patients in the PVB group requested additional morphine, whereas all patients in the ESPB group requested it (P = 0.004). The dermatome of sensory blockade was wider in the PVB group (7 vs. 4 levels, P = 0.019). No serious complications occurred in either group.

Conclusions: Compared to ESPB, PVB provided lower postoperative opioid requirements, lower pain scores, and wider sensory blockade after mastectomy.

背景:胸椎旁阻滞(PVB)是一种有效的乳房手术后疼痛控制区域阻滞。然而,意外刺穿邻近的重要结构可能会引起不良并发症。对于初学者来说,直立脊柱平面阻滞(ESPB)被认为是一种更安全的PVB替代方法。本研究旨在评价超声引导下PVB和ESPB在乳房手术后的镇痛效果。方法:这项随机对照试验在接受乳房切除术的患者中进行。44例女性随机分为PVB组和ESPB组。所有患者在全身麻醉前接受20ml 0.5%左布比卡因阻滞。主要观察指标为术后24小时吗啡需要量。其他值得关注的结果包括术后疼痛评分、首次要求镇痛的时间、感觉阻滞的皮肤分布、阻滞相关并发症和阿片类药物不良事件。结果:与ESPB组相比,PVB组24 h吗啡需取量明显降低(3.5±3.3 mg vs. 8.6±3.8 mg, P < 0.001)。PVB组总体疼痛评分也较低(P < 0.001)。PVB组只有14例患者要求增加吗啡,而ESPB组所有患者要求增加吗啡(P = 0.004)。PVB组感觉阻滞的皮区更宽(7个水平vs. 4个水平,P = 0.019)。两组均未发生严重并发症。结论:与ESPB相比,PVB在乳房切除术后提供更低的术后阿片类药物需求,更低的疼痛评分和更广泛的感觉阻塞。
{"title":"A randomized double-blind controlled study comparing erector spinae plane block and thoracic paravertebral block for postoperative analgesia after breast surgery.","authors":"Aumjit Wittayapairoj,&nbsp;Nattanan Sinthuchao,&nbsp;Ongart Somintara,&nbsp;Viriya Thincheelong,&nbsp;Wilawan Somdee","doi":"10.17085/apm.22157","DOIUrl":"https://doi.org/10.17085/apm.22157","url":null,"abstract":"<p><strong>Background: </strong>Thoracic paravertebral block (PVB) is an effective regional block for pain control after breast surgery. However, accidentally puncturing adjacent vital structures may cause undesirable complications. Erector spinae plane block (ESPB) has been considered a safer proxy of PVB for beginners. This study aimed to evaluate the analgesic effects of ultrasound-guidance PVB and ESPB after breast surgery.</p><p><strong>Methods: </strong>This randomized control trial was conducted in patients who underwent mastectomy. Forty-four females were randomly allocated into PVB group or ESPB group. All patients received a block with 20 ml of 0.5% levobupivacaine before general anesthesia. The primary outcome was the 24-h postoperative morphine requirements. The other outcomes of interest were postoperative pain scores, time to first analgesic request, dermatome of sensory blockade, block-related complications, and opioid adverse events.</p><p><strong>Results: </strong>The 24-h morphine requirements were significantly lower in PVB compared to the ESPB group (3.5 ± 3.3 vs. 8.6 ± 3.8 mg, P < 0.001). The overall pain scores were also lower in the PVB group (P < 0.001). Only 14 patients in the PVB group requested additional morphine, whereas all patients in the ESPB group requested it (P = 0.004). The dermatome of sensory blockade was wider in the PVB group (7 vs. 4 levels, P = 0.019). No serious complications occurred in either group.</p><p><strong>Conclusions: </strong>Compared to ESPB, PVB provided lower postoperative opioid requirements, lower pain scores, and wider sensory blockade after mastectomy.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"445-453"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/a4/apm-22157.PMC9663954.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Five-year all-cause mortality in critically ill liver transplant patients with coronary artery disease: analysis of acute-on chronic liver failure. 危重肝移植合并冠心病患者5年全因死亡率:急性-慢性肝衰竭分析
Pub Date : 2022-10-01 Epub Date: 2022-10-26 DOI: 10.17085/apm.22168
Hye-Mee Kwon, Jae Hwan Kim, Ji-Young Kim, Gyu-Sam Hwang

Background: Patients with acute-on-chronic liver failure (ACLF) are critically ill and have high waiting-list mortality. Although studies demonstrated that appropriately treated coronary artery disease (CAD) should not be regarded as a contraindication to liver transplant (LT), data regarding long-term outcomes in critically ill liver LT recipients are lacking. The aim of this study was to compare the rates of all-cause death at 5 years following LT in patients with ACLF with or without CAD.

Methods: Between 2010 and 2020, we evaluated 921 consecutive LT patients (MELD score, 32 ± 9) and ACLF classified by CLIF-C ACLF score. Up to 5-year all-cause death according to the CAD status was examined. CAD was defined as a preoperative history of coronary artery bypass graft or a percutaneous intervention and old myocardial infarction. Kaplan-Meier survival analysis was used.

Results: Up to 5 years, 212 (23.0%) of all ACLF patients (n = 921) in whom 17 (29.3%) of 58 CAD patients died. In patients with CAD (6.3%, 58/921), the Kaplan-Meier cumulative mortality rate at 5 years was numerically higher but was not statistically significant when compared with those without CAD (32.9% vs. 23.5%, log-rank, P = 0.25). In subgr oup analysis, there were comparable risks of cumulative mortalities at 5 years across the stratification of ACLF grade 1, 2, and 3 (log-rank P = 0.062, P = 0.72, and P = 0.999, respectively).

Conclusions: All-cause mortality is high in patients with ACLF after LT but is not related to the presence of revascularized or treated CAD, across the stratification of ACLF grades.

背景:急性伴慢性肝衰竭(ACLF)患者病情危重,等待名单死亡率高。尽管研究表明,适当治疗的冠状动脉疾病(CAD)不应被视为肝移植(LT)的禁忌症,但关于危重肝移植受体的长期预后的数据缺乏。本研究的目的是比较合并或不合并CAD的ACLF患者LT后5年的全因死亡率。方法:2010年至2020年,我们对921例连续LT患者(MELD评分,32±9)和CLIF-C ACLF评分分级的ACLF进行了评估。根据CAD状态检查了长达5年的全因死亡。CAD定义为术前冠状动脉搭桥术或经皮介入治疗史和陈旧性心肌梗死史。采用Kaplan-Meier生存分析。结果:5年内,所有ACLF患者(n = 921)中有212例(23.0%)死亡,其中58例CAD患者中有17例(29.3%)死亡。在CAD患者中(6.3%,58/921),5年Kaplan-Meier累积死亡率在数值上高于非CAD患者(32.9% vs. 23.5%, log-rank, P = 0.25)。在亚组分析中,ACLF 1级、2级和3级分层中,5年累积死亡风险可比较(log-rank分别为P = 0.062、P = 0.72和P = 0.999)。结论:肝移植后ACLF患者的全因死亡率很高,但与存在血运重建或治疗的CAD无关,跨ACLF等级分层。
{"title":"Five-year all-cause mortality in critically ill liver transplant patients with coronary artery disease: analysis of acute-on chronic liver failure.","authors":"Hye-Mee Kwon,&nbsp;Jae Hwan Kim,&nbsp;Ji-Young Kim,&nbsp;Gyu-Sam Hwang","doi":"10.17085/apm.22168","DOIUrl":"https://doi.org/10.17085/apm.22168","url":null,"abstract":"<p><strong>Background: </strong>Patients with acute-on-chronic liver failure (ACLF) are critically ill and have high waiting-list mortality. Although studies demonstrated that appropriately treated coronary artery disease (CAD) should not be regarded as a contraindication to liver transplant (LT), data regarding long-term outcomes in critically ill liver LT recipients are lacking. The aim of this study was to compare the rates of all-cause death at 5 years following LT in patients with ACLF with or without CAD.</p><p><strong>Methods: </strong>Between 2010 and 2020, we evaluated 921 consecutive LT patients (MELD score, 32 ± 9) and ACLF classified by CLIF-C ACLF score. Up to 5-year all-cause death according to the CAD status was examined. CAD was defined as a preoperative history of coronary artery bypass graft or a percutaneous intervention and old myocardial infarction. Kaplan-Meier survival analysis was used.</p><p><strong>Results: </strong>Up to 5 years, 212 (23.0%) of all ACLF patients (n = 921) in whom 17 (29.3%) of 58 CAD patients died. In patients with CAD (6.3%, 58/921), the Kaplan-Meier cumulative mortality rate at 5 years was numerically higher but was not statistically significant when compared with those without CAD (32.9% vs. 23.5%, log-rank, P = 0.25). In subgr oup analysis, there were comparable risks of cumulative mortalities at 5 years across the stratification of ACLF grade 1, 2, and 3 (log-rank P = 0.062, P = 0.72, and P = 0.999, respectively).</p><p><strong>Conclusions: </strong>All-cause mortality is high in patients with ACLF after LT but is not related to the presence of revascularized or treated CAD, across the stratification of ACLF grades.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"412-419"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/77/31/apm-22168.PMC9663955.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Do cross-food allergies to propofol exist? 异丙酚是否存在跨食物过敏?
Pub Date : 2022-10-01 Epub Date: 2022-10-20 DOI: 10.17085/apm.22195
Carles Espinós Ramírez, Marta Viñas Domingo, Anna Peig Font, Paula Gil Esteller, Maria José Castillo Marchuet, Maria Pilar Saura Foix, Juan Carlos Martín Sanchez, Maria Martinez García

Background: Propofol is a short and rapidly acting intravenous anesthetic extensively used for the induction and maintenance of general anesthesia. It is a lipid emulsion that contains soybean oil, purified egg phosphatide, and egg lecithin. Therefore, the package leaflet indicates that its administration is contraindicated in patients allergic to soy, eggs, or peanuts. Our study aimed to determine whether patients with proven food allergies are allergic to propofol.

Methods: Patients of all ages allergic to soy, eggs, or peanuts who agreed to undergo skin testing for propofol allergies were included. The subjects first underwent a skin test to confirm food allergies. If candidates were negative, they were excluded. If the result was positive, a propofol skin test was performed.

Results: Sixty-four patients with confirmed food allergies underwent a propofol skin test. Only one was positive in the propofol skin test (1.6%). The patient was allergic to peanuts and soybeans. These results reinforce the idea that there is no justification for avoiding propofol use in these subjects.

Conclusions: Propofol can be safely administered to patients allergic to soy, eggs, or peanuts. We recommend caution in patients with a history of anaphylaxis after ingestion of the above-mentioned foods.

背景:异丙酚是一种短效速效静脉麻醉药,广泛用于全身麻醉的诱导和维持。它是一种含有大豆油、纯化鸡蛋磷脂和鸡蛋卵磷脂的脂质乳液。因此,包装说明书上注明对大豆、鸡蛋或花生过敏的患者禁用本品。我们的研究旨在确定被证实对食物过敏的患者是否对异丙酚过敏。方法:包括所有年龄的对大豆、鸡蛋或花生过敏的患者,他们同意接受异丙酚过敏皮肤试验。受试者首先接受皮肤测试以确认食物过敏。如果候选人是否定的,他们将被排除在外。如果结果呈阳性,则进行异丙酚皮肤试验。结果:64例确诊食物过敏的患者进行了异丙酚皮肤试验。异丙酚皮试阳性1例(1.6%)。病人对花生和大豆过敏。这些结果强化了没有理由避免在这些受试者中使用异丙酚的观点。结论:异丙酚可以安全地用于对大豆、鸡蛋或花生过敏的患者。我们建议有过敏史的患者在摄入上述食物后要谨慎。
{"title":"Do cross-food allergies to propofol exist?","authors":"Carles Espinós Ramírez,&nbsp;Marta Viñas Domingo,&nbsp;Anna Peig Font,&nbsp;Paula Gil Esteller,&nbsp;Maria José Castillo Marchuet,&nbsp;Maria Pilar Saura Foix,&nbsp;Juan Carlos Martín Sanchez,&nbsp;Maria Martinez García","doi":"10.17085/apm.22195","DOIUrl":"https://doi.org/10.17085/apm.22195","url":null,"abstract":"<p><strong>Background: </strong>Propofol is a short and rapidly acting intravenous anesthetic extensively used for the induction and maintenance of general anesthesia. It is a lipid emulsion that contains soybean oil, purified egg phosphatide, and egg lecithin. Therefore, the package leaflet indicates that its administration is contraindicated in patients allergic to soy, eggs, or peanuts. Our study aimed to determine whether patients with proven food allergies are allergic to propofol.</p><p><strong>Methods: </strong>Patients of all ages allergic to soy, eggs, or peanuts who agreed to undergo skin testing for propofol allergies were included. The subjects first underwent a skin test to confirm food allergies. If candidates were negative, they were excluded. If the result was positive, a propofol skin test was performed.</p><p><strong>Results: </strong>Sixty-four patients with confirmed food allergies underwent a propofol skin test. Only one was positive in the propofol skin test (1.6%). The patient was allergic to peanuts and soybeans. These results reinforce the idea that there is no justification for avoiding propofol use in these subjects.</p><p><strong>Conclusions: </strong>Propofol can be safely administered to patients allergic to soy, eggs, or peanuts. We recommend caution in patients with a history of anaphylaxis after ingestion of the above-mentioned foods.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"381-385"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ec/2c/apm-22195.PMC9663949.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
General anesthesia and sleep: like and unlike. 全身麻醉与睡眠:相似与不同。
Pub Date : 2022-10-01 Epub Date: 2022-10-26 DOI: 10.17085/apm.22227
Jieun Jung, Tae Kim

General anesthesia and sleep have long been discussed in the neurobiological context owing to their commonalities, such as unconsciousness, immobility, non-responsiveness to external stimuli, and lack of memory upon returning to consciousness. Sleep is regulated by complex interactions between wake-promoting and sleep-promoting neural circuits. Anesthetics exert their effects partly by inhibiting wake-promoting neurons or activating sleep-promoting neurons. Unconscious but arousable sedation is more related to sleep-wake circuitries, whereas unconscious and unarousable anesthesia is independent of them. General anesthesia is notable for its ability to decrease sleep propensity. Conversely, increased sleep propensity due to insufficient sleep potentiates anesthetic effects. Taken together, it is plausible that sleep and anesthesia are closely related phenomena but not the same ones. Further investigations on the relationship between sleep and anesthesia are warranted.

全身麻醉和睡眠由于其共性,如无意识、不动、对外部刺激无反应、恢复意识后缺乏记忆,在神经生物学背景下一直被讨论。睡眠是由促进觉醒和促进睡眠的神经回路之间复杂的相互作用调节的。麻醉剂部分通过抑制促进觉醒的神经元或激活促进睡眠的神经元来发挥作用。无意识可唤醒镇静更多地与睡眠-觉醒回路有关,而无意识不可唤醒麻醉则与之无关。全身麻醉以其降低睡眠倾向的能力而闻名。相反,由于睡眠不足而增加的睡眠倾向会增强麻醉作用。综上所述,睡眠和麻醉是密切相关的现象,但不是同一种现象,这似乎是合理的。对睡眠和麻醉之间关系的进一步研究是必要的。
{"title":"General anesthesia and sleep: like and unlike.","authors":"Jieun Jung,&nbsp;Tae Kim","doi":"10.17085/apm.22227","DOIUrl":"https://doi.org/10.17085/apm.22227","url":null,"abstract":"<p><p>General anesthesia and sleep have long been discussed in the neurobiological context owing to their commonalities, such as unconsciousness, immobility, non-responsiveness to external stimuli, and lack of memory upon returning to consciousness. Sleep is regulated by complex interactions between wake-promoting and sleep-promoting neural circuits. Anesthetics exert their effects partly by inhibiting wake-promoting neurons or activating sleep-promoting neurons. Unconscious but arousable sedation is more related to sleep-wake circuitries, whereas unconscious and unarousable anesthesia is independent of them. General anesthesia is notable for its ability to decrease sleep propensity. Conversely, increased sleep propensity due to insufficient sleep potentiates anesthetic effects. Taken together, it is plausible that sleep and anesthesia are closely related phenomena but not the same ones. Further investigations on the relationship between sleep and anesthesia are warranted.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"343-351"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/22/f8/apm-22227.PMC9663953.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Educational value of spinal injection therapy videos in Korean YouTube for back pain patients. 韩国YouTube上脊椎注射治疗视频对背痛患者的教育价值。
Pub Date : 2022-10-01 Epub Date: 2022-08-01 DOI: 10.17085/apm.22134
Soo Bin Kim, Seung Bae Cho, Hyogyun Choi, Sehun Lim

Background: YouTube, the largest online video platform, has become increasingly popular as a source of health information to patients. The aim of the study was to assess whether Korean patients were well informed about spinal injection from YouTube.

Methods: Search for the keyword "cheog-chu ju-sa" in Korean language was done, and the quality of the 51 videos with the highest number of views was evaluated independently by two pain management doctors.

Results: The averages of global quality scores evaluated by the two doctors were 3.0 and 3.5 and modified DISCERN (mDISCERN) scores were 2.8 and 3.0, respectively. The Kappa statistic between the two doctors' scores was 0.285 and 0.417.

Conclusions: The percentage of low-quality videos with a global quality score of 2 or less is 18-36%, which indicated that these videos might provide inaccurate or misleading medical information to the patient. Pain clinic doctors should be wary of medically misleading information available on online platforms, such as YouTube, and strive to create and distribute professional quality educational materials.

背景:YouTube是最大的在线视频平台,作为向患者提供健康信息的来源越来越受欢迎。该研究的目的是评估韩国患者是否通过YouTube了解脊髓注射。方法:用韩语搜索关键词“cheogchu ju-sa”,由2名疼痛管理医生对观看次数最高的51个视频进行独立评价。结果:两名医生的整体质量评分平均值分别为3.0分和3.5分,改进的辨明(mDISCERN)评分分别为2.8分和3.0分。两名医生的评分Kappa统计值分别为0.285和0.417。结论:整体质量得分在2分及以下的低质量视频比例为18-36%,表明这些视频可能向患者提供不准确或误导性的医疗信息。疼痛诊所的医生应该警惕在线平台(如YouTube)上提供的医学误导性信息,并努力创建和分发专业质量的教育材料。
{"title":"Educational value of spinal injection therapy videos in Korean YouTube for back pain patients.","authors":"Soo Bin Kim,&nbsp;Seung Bae Cho,&nbsp;Hyogyun Choi,&nbsp;Sehun Lim","doi":"10.17085/apm.22134","DOIUrl":"https://doi.org/10.17085/apm.22134","url":null,"abstract":"<p><strong>Background: </strong>YouTube, the largest online video platform, has become increasingly popular as a source of health information to patients. The aim of the study was to assess whether Korean patients were well informed about spinal injection from YouTube.</p><p><strong>Methods: </strong>Search for the keyword \"cheog-chu ju-sa\" in Korean language was done, and the quality of the 51 videos with the highest number of views was evaluated independently by two pain management doctors.</p><p><strong>Results: </strong>The averages of global quality scores evaluated by the two doctors were 3.0 and 3.5 and modified DISCERN (mDISCERN) scores were 2.8 and 3.0, respectively. The Kappa statistic between the two doctors' scores was 0.285 and 0.417.</p><p><strong>Conclusions: </strong>The percentage of low-quality videos with a global quality score of 2 or less is 18-36%, which indicated that these videos might provide inaccurate or misleading medical information to the patient. Pain clinic doctors should be wary of medically misleading information available on online platforms, such as YouTube, and strive to create and distribute professional quality educational materials.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"429-433"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/36/apm-22134.PMC9663947.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Unexpected pulmonary edema and cardiac arrest following wedge resection of spontaneous pneumothorax -A case report. 自发性气胸楔形切除术后意外肺水肿及心脏骤停1例。
Pub Date : 2022-07-01 Epub Date: 2022-06-17 DOI: 10.17085/apm.21116
Woong Han, Gyu Seong Kim, Jong Min Lee, Chang Mook Lim, Hong Seuk Yang, Chang Yeong Jeong, Dong Ho Park

Background: Reexpansion pulmonary edema is a rare but potentially lethal complication. We report a case of suspected reexpansion pulmonary edema that led to cardiac arrest.

Case: A 16-year-old male patient underwent wedge resection due to right pneumothorax. The patient showed pink frothy sputum three hours following surgery, and a chest x-ray showed right unilateral pulmonary edema. Thirteen hours following surgery, the patient continuously showed pink frothy sputum and presented with severe hypoxemia, tachypnea, and tachycardia. After transferring to the intensive care unit (ICU), he developed ventricular tachycardia. Cardiopulmonary resuscitation was performed for 32 min. Chest X-ray showed diffuse bilateral pulmonary edema. Extracorporeal membrane oxygenation was performed. During the 65 days of ICU care, the patient became mentally alert. However, follow-up echocardiography revealed severe heart failure.

Conclusions: Rexpansion pulmonary edema can rapidly progress to diffuse bilateral pulmonary edema. Therefore, careful observation is required for the patients who show signs of pulmonary edema after reexpansion.

背景:再扩张性肺水肿是一种罕见但潜在致命的并发症。我们报告一例疑似再扩张肺水肿导致心脏骤停。病例:一位16岁男性患者因右侧气胸行楔形切除术。术后3小时患者出现粉红色泡沫痰,胸部x线片显示右侧单侧肺水肿。术后13小时,患者持续出现粉红色痰泡,并出现严重低氧血症、呼吸急促、心动过速。转入重症监护室(ICU)后,他出现室性心动过速。心肺复苏32分钟。胸片示双侧弥漫性肺水肿。体外膜氧合。在ICU护理的65天中,患者的精神变得清醒。然而,随访超声心动图显示严重的心力衰竭。结论:扩张性肺水肿可迅速发展为弥漫性双侧肺水肿。因此,对于再扩张后有肺水肿征象的患者,需要仔细观察。
{"title":"Unexpected pulmonary edema and cardiac arrest following wedge resection of spontaneous pneumothorax -A case report.","authors":"Woong Han,&nbsp;Gyu Seong Kim,&nbsp;Jong Min Lee,&nbsp;Chang Mook Lim,&nbsp;Hong Seuk Yang,&nbsp;Chang Yeong Jeong,&nbsp;Dong Ho Park","doi":"10.17085/apm.21116","DOIUrl":"https://doi.org/10.17085/apm.21116","url":null,"abstract":"<p><strong>Background: </strong>Reexpansion pulmonary edema is a rare but potentially lethal complication. We report a case of suspected reexpansion pulmonary edema that led to cardiac arrest.</p><p><strong>Case: </strong>A 16-year-old male patient underwent wedge resection due to right pneumothorax. The patient showed pink frothy sputum three hours following surgery, and a chest x-ray showed right unilateral pulmonary edema. Thirteen hours following surgery, the patient continuously showed pink frothy sputum and presented with severe hypoxemia, tachypnea, and tachycardia. After transferring to the intensive care unit (ICU), he developed ventricular tachycardia. Cardiopulmonary resuscitation was performed for 32 min. Chest X-ray showed diffuse bilateral pulmonary edema. Extracorporeal membrane oxygenation was performed. During the 65 days of ICU care, the patient became mentally alert. However, follow-up echocardiography revealed severe heart failure.</p><p><strong>Conclusions: </strong>Rexpansion pulmonary edema can rapidly progress to diffuse bilateral pulmonary edema. Therefore, careful observation is required for the patients who show signs of pulmonary edema after reexpansion.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"298-303"},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d3/be/apm-21116.PMC9346198.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40576566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anesthesia and pain medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1